Healthcare MoneyTree™ report: Q2 2019

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of Q2'19 activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

US Healthcare deal share by stage

Early and expansion stage deals made up the majority of deals.

 

In Q2'19 early and expansion stage deals made up of the majority of deals

Highlights for this quarter's report include, but are not limited to:

  • Funding for VC-backed Healthcare companies in US raised $4.6B in 195 deals.
  • Compared to Q1’19, the number of deals closed in Q2’19 increased by 12% from 174 to 195.
  • A total of $1.5B was raised this quarter through 11 mega-rounds, making up 32% of total deal dollars raised in Q2’19, relatively consistent with prior quarter.
  • In Q2’19, Silicon Valley raised $1.1B through 44 deals and is the leading region this quarter in terms of dollars raised. Out of the eleven mega-rounds in Q2’19, one was closed in New England.

Contact us

Ousmane Caba

Partner, US Pharmaceuticals and Life Sciences, PwC US

Laura Robinette

US Pharmaceutical & Life Sciences Assurance Leader, PwC US

Tim Weld

US Health Industries Assurance Leader, PwC US

Follow us